-
1
-
-
33646014162
-
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
-
A.J. Garber, J. Wahlen, and T. Wahl Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) Diabetes Obes Metab 8 2006 58 66
-
(2006)
Diabetes Obes Metab
, vol.8
, pp. 58-66
-
-
Garber, A.J.1
Wahlen, J.2
Wahl, T.3
-
2
-
-
44049097336
-
Pramlintide,the synthetic analogue of amylin: Physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
-
B.J. Hoogwerf, K.B. Doshi, and D. Diab Pramlintide, the synthetic analog of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk Vasc Health Risk Manag 4 2008 355 362 (Pubitemid 351711964)
-
(2008)
Vascular Health and Risk Management
, vol.4
, Issue.2
, pp. 355-362
-
-
Hoogwerf, B.J.1
Doshi, K.B.2
Diab, D.3
-
3
-
-
67649666737
-
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomized, parallel-group, multinational, open-label trial (LEAD-6)
-
J. Buse, J. Rosenstock, and G. Sesti Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomized, parallel-group, multinational, open-label trial (LEAD-6) Lancet 374 2009 39 47
-
(2009)
Lancet
, vol.374
, pp. 39-47
-
-
Buse, J.1
Rosenstock, J.2
Sesti, G.3
-
4
-
-
79551615182
-
Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: A randomized, controlled trial
-
J.B. Buse, R.M. Bergenstal, and L.C. Glass Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial Ann Intern Med 154 2011 103 112
-
(2011)
Ann Intern Med
, vol.154
, pp. 103-112
-
-
Buse, J.B.1
Bergenstal, R.M.2
Glass, L.C.3
-
5
-
-
84862903186
-
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets
-
J.H. DeVries, S.C. Bain, and H.W. Rodbard Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets Diabetes Care 35 2012 1446 1454
-
(2012)
Diabetes Care
, vol.35
, pp. 1446-1454
-
-
Devries, J.H.1
Bain, S.C.2
Rodbard, H.W.3
-
6
-
-
0242269000
-
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
DOI 10.2337/diacare.26.11.3080
-
M.C. Riddle, J. Rosenstock, J. Gerich Insulin Glargine 4002 Study Investigators The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 2003 3080 3086 (Pubitemid 37339502)
-
(2003)
Diabetes Care
, vol.26
, Issue.11
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
7
-
-
19944368427
-
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: Comparison of two treatment algorithms using insulin glargine
-
DOI 10.2337/diacare.28.6.1282
-
M. Davies, F. Storms, and S. Shutler Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine Diabetes Care 28 2005 1282 1288 (Pubitemid 40756686)
-
(2005)
Diabetes Care
, vol.28
, Issue.6
, pp. 1282-1288
-
-
Davies, M.1
Storms, F.2
Shutler, S.3
Bianchi-Biscay, M.4
Gomis, R.5
-
8
-
-
33845236398
-
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes
-
DOI 10.1016/j.clinthera.2006.10.020, PII S0149291806002608
-
A. Philis-Tsimikas, G. Charpentier, P. Clauson, G.M. Ravn, V.L. Roberts, and B. Thorsteinsson Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes Clin Ther 28 10 2006 1569 1581 (Pubitemid 44856694)
-
(2006)
Clinical Therapeutics
, vol.28
, Issue.10
, pp. 1569-1581
-
-
Philis-Tsimikas, A.1
Charpentier, G.2
Clauson, P.3
Ravn, G.M.4
Roberts, V.L.5
Thorsteinsson, B.6
-
9
-
-
65549131199
-
Patient-directed titration for achieving glycaemic goals using once-daily basal insulin analog: An assessment of two different fasting plasma glucose targets - The TITRATE study
-
TITRATE Study Group
-
L. Blonde, M. Merilainen, V. Karwe, P. Raskin TITRATE Study Group Patient-directed titration for achieving glycaemic goals using once-daily basal insulin analog: an assessment of two different fasting plasma glucose targets - the TITRATE study Diabetes Obes Metab 11 6 2009 623 631
-
(2009)
Diabetes Obes Metab
, vol.11
, Issue.6
, pp. 623-631
-
-
Blonde, L.1
Merilainen, M.2
Karwe, V.3
Raskin, P.4
-
10
-
-
84882271234
-
Initiating basal insulin therapy in type 2 diabetes: Practical steps to optimize glycemic control
-
A. Philis-Tsimikas Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control Am J Med 126 Suppl 2013 S21 S27
-
(2013)
Am J Med
, vol.126
, Issue.SUPPL.
-
-
Philis-Tsimikas, A.1
-
11
-
-
0042166232
-
1c
-
DOI 10.2337/diacare.26.3.881
-
L. Monnier, H. Lapinski, and C. Colette Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 2003 881 885 (Pubitemid 36929359)
-
(2003)
Diabetes Care
, vol.26
, Issue.3
, pp. 881-885
-
-
Monnier, L.1
Lapinski, H.2
Colette, C.3
-
12
-
-
84864285795
-
Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
S.E. Inzucchi, R.M. Bergenstal, and J.B. Buse Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 55 2012 1577 1596
-
(2012)
Diabetologia
, vol.55
, pp. 1577-1596
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
13
-
-
55449131463
-
Orals Plus Apidra and LANTUS (OPAL) Study Group. Introducing a simplified approach to insulin therapy in type 2 diabetes: A comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
-
M.R. Lankisch, K.C. Ferlinz, J.L. Leahy, and W.A. Scherbaum Orals Plus Apidra and LANTUS (OPAL) Study Group. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs Diabetes Obes Metab 10 2008 1178 1185
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 1178-1185
-
-
Lankisch, M.R.1
Ferlinz, K.C.2
Leahy, J.L.3
Scherbaum, W.A.4
-
14
-
-
80054079094
-
A comparison of two intensification regimens with rapid-acting insulin aspart in type 2 diabetes inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: The step-wise randomized study
-
L. Meneghini, H. Mersebach, and S. Kumar A comparison of two intensification regimens with rapid-acting insulin aspart in type 2 diabetes inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study Endocr Pract 17 2011 727 736
-
(2011)
Endocr Pract
, vol.17
, pp. 727-736
-
-
Meneghini, L.1
Mersebach, H.2
Kumar, S.3
-
15
-
-
79959645873
-
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure
-
M.B. Davidson, P. Raskin, and R.J. Tanenberg A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure Endocr Pract 17 2011 395 403
-
(2011)
Endocr Pract
, vol.17
, pp. 395-403
-
-
Davidson, M.B.1
Raskin, P.2
Tanenberg, R.J.3
-
16
-
-
49649123535
-
Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
-
R.M. Bergenstal, M. Johnson, and M.A. Powers Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine Diabetes Care 31 2008 1305 1310
-
(2008)
Diabetes Care
, vol.31
, pp. 1305-1310
-
-
Bergenstal, R.M.1
Johnson, M.2
Powers, M.A.3
-
17
-
-
84872228197
-
Near normoglycaemic control under supplementary insulin therapy in type 2 diabetes with insulin aspart and insulin detemir - Is a fixed-dose regimen as effective as a flexible therapy regimen?
-
S412
-
K. Milek, E. Wizemann, and S. Martin Near normoglycaemic control under supplementary insulin therapy in type 2 diabetes with insulin aspart and insulin detemir - is a fixed-dose regimen as effective as a flexible therapy regimen? Diabetologia 50 Suppl 1 2007 S412
-
(2007)
Diabetologia
, vol.50
, Issue.SUPPL. 1
-
-
Milek, K.1
Wizemann, E.2
Martin, S.3
-
18
-
-
44849091537
-
When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study
-
DOI 10.1111/j.1742-1241.2008.01792.x
-
H.C. Jang, S. Guler, M. Shestakova PRESENT Study Group When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study Int J Clin Pract 62 2008 1013 1018 (Pubitemid 351793600)
-
(2008)
International Journal of Clinical Practice
, vol.62
, Issue.7
, pp. 1013-1018
-
-
Jang, H.C.1
Guler, S.2
Shestakova, M.3
-
19
-
-
58149177354
-
Comparison of insulin analog regimens in people with type 2 diabetes mellitus in the PREFER Study: A randomized controlled trial
-
A. Liebl, R. Prager, and K. Binz Comparison of insulin analog regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial Diabetes Obes Metab 11 2009 45 52
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 45-52
-
-
Liebl, A.1
Prager, R.2
Binz, K.3
-
20
-
-
70350534273
-
Three-year efficacy of complex insulin regimens in type 2 diabetes
-
4-T Study Group
-
R.R. Holman, A.J. Farmer, M.J. Davies 4-T Study Group Three-year efficacy of complex insulin regimens in type 2 diabetes N Engl J Med 361 2009 1736 1747
-
(2009)
N Engl J Med
, vol.361
, pp. 1736-1747
-
-
Holman, R.R.1
Farmer, A.J.2
Davies, M.J.3
-
21
-
-
73349119110
-
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
-
T. Vilsbøll, J. Rosenstock, and Yki-Järvinen Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes Diabetes Obes Metab 12 2010 167 177
-
(2010)
Diabetes Obes Metab
, vol.12
, pp. 167-177
-
-
Vilsbøll, T.1
Rosenstock, J.2
Yki-Järvinen3
-
22
-
-
69549130787
-
Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes
-
M. Riddle, R. Pencek, and S. Charenkavanich Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes Diabetes Care 32 2009 1577 1582
-
(2009)
Diabetes Care
, vol.32
, pp. 1577-1582
-
-
Riddle, M.1
Pencek, R.2
Charenkavanich, S.3
-
23
-
-
78651338445
-
Standards of medical care in diabetes - 2011
-
American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
-
(2011)
Diabetes Care
, vol.34
, Issue.SUPPL. 1
-
-
-
24
-
-
74349094720
-
Perioperative management of diabetes: Translating evidence into practice
-
J. Meneghini Perioperative management of diabetes: translating evidence into practice Cleve Clin J Med 76 Suppl 4 2009 S53 S59
-
(2009)
Cleve Clin J Med
, vol.76
, Issue.SUPPL. 4
-
-
Meneghini, J.1
-
25
-
-
84882276623
-
AACE comprehensive diabetes management algorithm 2013
-
A.J. Garber, M.J. Abrahamson, and J.I. Barzilay AACE comprehensive diabetes management algorithm 2013 Endocr Pract 19 2013 327 336
-
(2013)
Endocr Pract
, vol.19
, pp. 327-336
-
-
Garber, A.J.1
Abrahamson, M.J.2
Barzilay, J.I.3
-
26
-
-
77950813140
-
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: Systematic review and economic evaluation
-
E. Cummins, P. Royle, and A. Snaith Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 34, xi-xvi 2010 1 181
-
(2010)
Health Technol Assess
, vol.14
, Issue.34
, pp. 1-181
-
-
Cummins, E.1
Royle, P.2
Snaith, A.3
-
27
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
DOI 10.1056/NEJMoa0802743
-
H.C. Gerstein, M.E. Miller, and R.P. Byington Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559 (Pubitemid 351831356)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Friedewald, W.T.1
Buse, J.B.2
Bigger, J.T.3
Byington, R.P.4
Cushman, W.C.5
Gerstein, H.C.6
Ginsberg, H.N.7
Goff Jr., D.C.8
Grimm Jr., R.H.9
Ismail-Beigi, F.10
Probstfield, J.L.11
Simons-Morton, D.G.12
-
28
-
-
74949138626
-
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study
-
M.E. Miller, D.E. Bonds, and H.C. Gerstein The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study BMJ 340 2010 b5444
-
(2010)
BMJ
, vol.340
, pp. 5444
-
-
Miller, M.E.1
Bonds, D.E.2
Gerstein, H.C.3
-
29
-
-
63149103614
-
Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
-
J.S. Skyler, R. Bergenstal, and R.O. Bonow Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care 32 2009 187 192
-
(2009)
Diabetes Care
, vol.32
, pp. 187-192
-
-
Skyler, J.S.1
Bergenstal, R.2
Bonow, R.O.3
-
30
-
-
33846254561
-
Basal insulin or premix analogue therapy in type 2 diabetes patients
-
DOI 10.1016/j.ejim.2006.09.006, PII S0953620506002512
-
P.R. Raskin, P.A. Hollander, A. Lewin INITIATE Study Group Basal insulin or premix analogue therapy in type 2 diabetes patients Eur J Intern Med 18 2007 56 62 (Pubitemid 46098904)
-
(2007)
European Journal of Internal Medicine
, vol.18
, Issue.1
, pp. 56-62
-
-
Raskin, P.R.1
Hollander, P.A.2
Lewin, A.3
Gabbay, R.A.4
Bode, B.5
Garber, A.J.6
-
31
-
-
71149098726
-
A(1c) control in primary care setting: Self-titrating an insulin analog pre-mix (INITIATEplus trial)
-
D.S. Oyer, M.D. Shepherd, and F.C. Coulter A(1c) control in primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial) Am J Med 122 2009 1043 1049
-
(2009)
Am J Med
, vol.122
, pp. 1043-1049
-
-
Oyer, D.S.1
Shepherd, M.D.2
Coulter, F.C.3
-
32
-
-
77954783077
-
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial
-
W.F. Miser, R. Arakaki, and H. Jiang Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial Clin Ther 32 2010 896 908
-
(2010)
Clin Ther
, vol.32
, pp. 896-908
-
-
Miser, W.F.1
Arakaki, R.2
Jiang, H.3
-
33
-
-
77953601896
-
Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: A pooled analysis of treat-to-target trials
-
V. Fonseca, J. Davidson, and P. Home Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials Curr Med Res Opin 26 2010 1621 1628
-
(2010)
Curr Med Res Opin
, vol.26
, pp. 1621-1628
-
-
Fonseca, V.1
Davidson, J.2
Home, P.3
-
34
-
-
38149073314
-
Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
-
J. Rosenstock, A.J. Ahmann, and G. Colon Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy Diabetes Care 31 2008 20 25
-
(2008)
Diabetes Care
, vol.31
, pp. 20-25
-
-
Rosenstock, J.1
Ahmann, A.J.2
Colon, G.3
-
35
-
-
73349140858
-
Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
-
A. Fritsche, M. Larbig, and D. Owens Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study Diabetes Obes Metab 12 2010 115 123
-
(2010)
Diabetes Obes Metab
, vol.12
, pp. 115-123
-
-
Fritsche, A.1
Larbig, M.2
Owens, D.3
-
36
-
-
65649091666
-
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: A subgroup analysis of the IMPROVE observational study
-
J. Gumprecht, M. Benroubi, and V. Borzi Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study Int J Clin Pract 63 2009 966 972
-
(2009)
Int J Clin Pract
, vol.63
, pp. 966-972
-
-
Gumprecht, J.1
Benroubi, M.2
Borzi, V.3
-
37
-
-
12844265257
-
Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
-
DOI 10.2337/diacare.28.2.260
-
P. Raskin, E. Allen, and P. Hollander Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs Diabetes Care 28 2005 260 265 (Pubitemid 40170923)
-
(2005)
Diabetes Care
, vol.28
, Issue.2
, pp. 260-265
-
-
Raskin, P.1
Allen, E.2
Hollander, P.3
Lewin, A.4
Gabbay, R.A.5
Hu, P.6
Bode, B.7
Garber, A.8
-
38
-
-
84882288796
-
-
Merck & Co., Inc. Accessed October 26, 2012
-
Merck & Co., Inc. Januvia (sitagliptin) summary of product characteristics. Available at: http://www.medicines.org.uk/emc/medicine/19609/ SPC/. Accessed October 26, 2012.
-
Januvia (Sitagliptin) Summary of Product Characteristics
-
-
-
39
-
-
84882265000
-
-
Amylin Pharmaceuticals, Inc. Accessed October 26, 2012
-
Amylin Pharmaceuticals, Inc. Symlin (pramlintide acetate) prescribing information. Available at: https://www.symlin.com/pdf/symlin-pi-combined.pdf. Accessed October 26, 2012.
-
Symlin (Pramlintide Acetate) Prescribing Information
-
-
-
40
-
-
77956600662
-
-
Amylin Pharmaceuticals, Inc. Accessed October 26, 2012
-
Amylin Pharmaceuticals, Inc. Byetta® (exenatide) prescribing information. Available at: http://documents.byetta.com/Byetta-PI.pdf. Accessed October 26, 2012.
-
Byetta® (Exenatide) Prescribing Information
-
-
-
41
-
-
84900559862
-
-
Amylin Pharmaceuticals, Inc. Accessed October 26, 2012
-
Amylin Pharmaceuticals, Inc. Byetta® (exenatide) summary of product characteristics. Available at: http://www.medicines.org.uk/emc/medicine/19257. Accessed October 26, 2012.
-
Byetta® (Exenatide) Summary of Product Characteristics
-
-
-
44
-
-
84882283195
-
-
Novo Nordisk A/S. Accessed October 26, 2012
-
Novo Nordisk A/S. Victoza® (liraglutide) prescribing information. Available at http://www.novo-pi.com/victoza.pdf. Accessed October 26, 2012.
-
Victoza® (Liraglutide) Prescribing Information
-
-
|